391 related articles for article (PubMed ID: 36353640)
1. Cancer immunotherapy strategies that target the cGAS-STING pathway.
Tian Z; Zeng Y; Peng Y; Liu J; Wu F
Front Immunol; 2022; 13():996663. PubMed ID: 36353640
[TBL] [Abstract][Full Text] [Related]
2. Nanodelivery of cGAS-STING activators for tumor immunotherapy.
Guo J; Huang L
Trends Pharmacol Sci; 2022 Nov; 43(11):957-972. PubMed ID: 36089410
[TBL] [Abstract][Full Text] [Related]
3. Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy.
Luo K; Li N; Ye W; Gao H; Luo X; Cheng B
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889509
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
[TBL] [Abstract][Full Text] [Related]
5. Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy.
Wang Y; Liu Y; Zhang J; Peng Q; Wang X; Xiao X; Shi K
Acta Biomater; 2024 Mar; 176():51-76. PubMed ID: 38237711
[TBL] [Abstract][Full Text] [Related]
6. cGAS/STING cross-talks with cell cycle and potentiates cancer immunotherapy.
Long ZJ; Wang JD; Xu JQ; Lei XX; Liu Q
Mol Ther; 2022 Mar; 30(3):1006-1017. PubMed ID: 35121107
[TBL] [Abstract][Full Text] [Related]
7. The cyclic guanosine monophosphate synthase-stimulator of interferon genes pathway as a potential target for tumor immunotherapy.
Chen R; Liu M; Jiang Q; Meng X; Wei J
Front Immunol; 2023; 14():1121603. PubMed ID: 37153627
[TBL] [Abstract][Full Text] [Related]
8. cGAS-STING signaling in cancer immunity and immunotherapy.
Du H; Xu T; Cui M
Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
[TBL] [Abstract][Full Text] [Related]
9. Targeting STING for cancer immunotherapy: From mechanisms to translation.
Huang R; Ning Q; Zhao J; Zhao X; Zeng L; Yi Y; Tang S
Int Immunopharmacol; 2022 Dec; 113(Pt A):109304. PubMed ID: 36252492
[TBL] [Abstract][Full Text] [Related]
10. Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.
Pan X; Zhang W; Guo H; Wang L; Wu H; Ding L; Yang B
Biochem Pharmacol; 2023 Jul; 213():115596. PubMed ID: 37201875
[TBL] [Abstract][Full Text] [Related]
11. The cGAS/STING Pathway: A Novel Target for Cancer Therapy.
Gan Y; Li X; Han S; Liang Q; Ma X; Rong P; Wang W; Li W
Front Immunol; 2021; 12():795401. PubMed ID: 35046953
[TBL] [Abstract][Full Text] [Related]
12. STING pathway as a cancer immunotherapy: Progress and challenges in activating anti-tumor immunity.
Tabar MMM; Fathi M; Kazemi F; Bazregari G; Ghasemian A
Mol Biol Rep; 2024 Apr; 51(1):487. PubMed ID: 38578532
[TBL] [Abstract][Full Text] [Related]
13. cGAS-STING Pathway as the Target of Immunotherapy for Lung Cancer.
Dan Q; Yang Y; Ge H
Curr Cancer Drug Targets; 2023; 23(5):354-362. PubMed ID: 36380440
[TBL] [Abstract][Full Text] [Related]
14. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies.
Zhang J; Yu S; Peng Q; Wang P; Fang L
Cancer Biol Med; 2024 Jan; 21(1):45-64. PubMed ID: 38172538
[TBL] [Abstract][Full Text] [Related]
15. cGAS-STING pathway in cancer biotherapy.
Wang Y; Luo J; Alu A; Han X; Wei Y; Wei X
Mol Cancer; 2020 Sep; 19(1):136. PubMed ID: 32887628
[TBL] [Abstract][Full Text] [Related]
16. Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches.
Khoo LT; Chen LY
EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30446584
[TBL] [Abstract][Full Text] [Related]
17. Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy.
Li A; Yi M; Qin S; Song Y; Chu Q; Wu K
J Hematol Oncol; 2019 Apr; 12(1):35. PubMed ID: 30935414
[TBL] [Abstract][Full Text] [Related]
18. The Function of cGAS-STING Pathway in Treatment of Pancreatic Cancer.
Mohseni G; Li J; Ariston Gabriel AN; Du L; Wang YS; Wang C
Front Immunol; 2021; 12():781032. PubMed ID: 34858438
[TBL] [Abstract][Full Text] [Related]
19. The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer.
Kwon J; Bakhoum SF
Cancer Discov; 2020 Jan; 10(1):26-39. PubMed ID: 31852718
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-Mediated STING Activation for Cancer Immunotherapy.
Li Y; Li X; Yi J; Cao Y; Qin Z; Zhong Z; Yang W
Adv Healthc Mater; 2023 Jul; 12(19):e2300260. PubMed ID: 36905358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
